Ocular Therapeutix Ownership | Who Owns Ocular Therapeutix?


OverviewForecastRevenueFinancialsChartTranscripts

Ocular Therapeutix Ownership Summary


Ocular Therapeutix is owned by 81.09% institutional investors, 3.44% insiders, and 15.47% retail investors. Blackrock is the largest institutional shareholder, holding 8.73% of OCUL shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.02% of its assets in Ocular Therapeutix shares.

OCUL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOcular Therapeutix81.09%3.44%15.47%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock11.52M8.73%$78.80M
Summer road13.87M8.31%$118.45M
Deep track capital, lp12.84M7.69%$109.62B
Vr adviser12.76M7.64%$108.99M
Blackrock funding, inc. /de11.85M7.09%$101.17M
Vanguard group8.48M5.08%$72.45M
Avoro capital advisors8.06M4.83%$68.83M
Tcg crossover management5.32M3.19%$45.43M
State street3.92M2.97%$26.82M
Opaleye management4.34M2.60%$37.08M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Summer road13.87M98.61%$118.45M
Acuta capital partners1.11M9.55%$9.49B
Vr adviser12.76M7.48%$108.99M
Opaleye management4.34M6.49%$37.08M
Rosalind advisors1.13M4.93%$9.64M
Tcg crossover management5.32M4.44%$45.43M
Deltec asset management2.62M4.42%$22.34M
Deep track capital, lp12.84M4.09%$109.62B
Logos global management lp3.50M3.50%$29.89M
Octagon capital advisors lp2.42M3.41%$20.71M

Top Buyers

HolderShares% AssetsChange
Blackrock11.52M0.00%3.46M
State street3.92M0.00%1.52M
Point72 asset management2.94M0.06%895.30K
Bank of america corp /de/1.04M0.00%809.12K
Blackrock funding, inc. /de11.85M0.00%492.32K

Top Sellers

HolderShares% AssetsChange
Assenagon asset management---2.83M
Perceptive advisors1.08M0.25%-2.25M
Braidwell lp---2.24M
Great point partners---1.73M
Opaleye management4.34M6.49%-682.50K

New Positions

HolderShares% AssetsChangeValue
First trust advisors lp212.94K0.00%212.94K$1.82M
Raymond james financial201.62K0.00%201.62K$1.72M
Saturn v capital management191.46K0.64%191.46K$1.64M
Balyasny asset management97.55K0.00%97.55K$833.10K
Courier capital56.44K0.03%56.44K$481.98K

Sold Out

HolderChange
Financial gravity asset management-1.00
Parallel advisors-1.00
Nelson, van denburg & campbell wealth management group-17.00
Signaturefd-76.00
Bessemer group-160.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20252028.60%137,366,9062.63%811.26%93-1.06%6057.89%
Dec 31, 20241772.31%128,615,765-8.11%771.10%8914.10%36-21.74%
Sep 30, 202417213.91%139,954,0592.07%830.78%79-13.19%4670.37%
Jun 30, 2024151-0.66%137,118,55510.64%1031.18%91-14.95%2717.39%
Mar 31, 202415224.59%123,928,59468.68%931.24%10769.84%23-23.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv4.81M3.02%97.26K
Vanguard US Total Market Shares ETF4.64M2.92%-
iShares Russell 2000 ETF4.05M2.54%1.98K
Vanguard Institutional Extnd Mkt Idx Tr2.01M1.26%3.01K
Fidelity Small Cap Index1.54M0.97%10.23K
iShares Russell 2000 Growth ETF1.38M0.87%-
State St Russell Sm/Mid Cp® Indx SL Cl I910.16K0.57%3.49K
State St Russell Sm/Mid Cp® Indx NL Cl C910.16K0.57%3.49K
Artisan International Small-Mid Investor806.65K0.51%-79.37K
Artisan Non-U.S. Small-Mid Growth Comp806.65K0.51%-79.37K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 02, 2025Waheed Nadia Chief Medical OfficerSell$111.58K
May 23, 2025Nayak Sanjay Chief Strategy OfficerSell$13.35K
May 23, 2025Kaiser Peter Chief Development OfficerSell$21.32K
May 23, 2025Heier Jeffrey S. Chief Scientific OfficerSell$21.71K
May 23, 2025Dugel Pravin See RemarksSell$152.35K

Insider Transactions Trends


DateBuySell
2025 Q215
2025 Q1-6
2024 Q4-4
2024 Q3-2
2024 Q2-2

OCUL Ownership FAQ


Who Owns Ocular Therapeutix?

Ocular Therapeutix shareholders are primarily institutional investors at 81.09%, followed by 3.44% insiders and 15.47% retail investors. The average institutional ownership in Ocular Therapeutix's industry, Biotech Stocks , is 63.96%, which Ocular Therapeutix exceeds.

Who owns the most shares of Ocular Therapeutix?

Ocular Therapeutix’s largest shareholders are Blackrock (11.52M shares, 8.73%), Summer road (13.87M shares, 8.31%), and Deep track capital, lp (12.84M shares, 7.69%). Together, they hold 24.72% of Ocular Therapeutix’s total shares outstanding.

Does Blackrock own Ocular Therapeutix?

Yes, BlackRock owns 8.73% of Ocular Therapeutix, totaling 11.52M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 78.8M$. In the last quarter, BlackRock increased its holdings by 3.46M shares, a 42.87% change.

Who is Ocular Therapeutix’s biggest shareholder by percentage of total assets invested?

Summer road is Ocular Therapeutix’s biggest shareholder by percentage of total assets invested, with 98.61% of its assets in 13.87M Ocular Therapeutix shares, valued at 118.45M$.

Who is the top mutual fund holder of Ocular Therapeutix shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Ocular Therapeutix shares, with 3.02% of its total shares outstanding invested in 4.81M Ocular Therapeutix shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools